{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"NANOBIOTIX Announces Closing of Global Offering - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"mSrkXgZw4s\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-closing-of-global-offering\/\">NANOBIOTIX Announces Closing of Global Offering<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/nanobiotix-announces-closing-of-global-offering\/embed\/#?secret=mSrkXgZw4s\" width=\"600\" height=\"338\" title=\"&#8220;NANOBIOTIX Announces Closing of Global Offering&#8221; &#8212; Market Newsdesk\" data-secret=\"mSrkXgZw4s\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) &#8212; NANOBIOTIX (Euronext: NANO \u2013 NASDAQ: NBTX \u2013 \u201cNanobiotix\u201d or the \u201cCompany\u201d), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announces the closing today (the \u201cClosing\u201d) of its global offering (the \u201cGlobal Offering\u201d), including in respect of the earlier total exercise by the underwriters of their option (the \u201cOption\u201d) to purchase additional new ordinary shares in the form of additional American Depositary Shares (the \u201cAdditional ADSs\u201d). Following the full exercise of the Option, the total number of ordinary shares (each an \u201cOrdinary Share\u201d), of the Company and pre-funded warrants to subscribe for one Ordinary Share each (the \u201cPFW\u201d) issued &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyNjg1NyM3NjIxODU5IzEwMTExNjI="}